We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.27%
2 Consumer Discretionary 9.91%
3 Healthcare 7.11%
4 Financials 6.94%
5 Communication Services 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THRY icon
3901
Thryv Holdings
THRY
$184M
$531K ﹤0.01%
+17,674
New +$555K
TIGR
3902
CALL
UP Fintech Holding
TIGR
$858M
$530K ﹤0.01%
50,000
LXP icon
3903
LXP Industrial Trust
LXP
$3.53B
$528K ﹤0.01%
8,276
-13,040
-61% -$854K
APP icon
3904
Applovin
APP
$140B
$527K ﹤0.01%
+7,281
New +$495K
CP icon
3905
Canadian Pacific Kansas City
CP
$81.4B
$527K ﹤0.01%
+8,075
New +$575K
VITL icon
3906
CALL
Vital Farms
VITL
$592M
$527K ﹤0.01%
30,000
LKFT
3907
PUT
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$526K ﹤0.01%
10,000
IPSC icon
3908
Century Therapeutics
IPSC
$370M
$525K ﹤0.01%
+20,856
New +$565K
ASZ.WS
3909
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
$525K ﹤0.01%
499,999
+333,333
+200% +$372K
VWTR
3910
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$525K ﹤0.01%
46,117
-24,004
-34% -$314K
NWG icon
3911
NatWest
NWG
$70.6B
$524K ﹤0.01%
160,558
+139,183
+651% +$866K
OHI icon
3912
PUT
Omega Healthcare
OHI
$15.4B
$524K ﹤0.01%
+17,500
New +$602K
TRHC
3913
PUT
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$524K ﹤0.01%
+20,000
New +$737K
FRST icon
3914
Primis Financial Corp
FRST
$398M
$522K ﹤0.01%
36,039
-12,532
-26% -$187K
OSIS icon
3915
OSI Systems
OSIS
$3.64B
$521K ﹤0.01%
5,501
-936
-15% -$91.1K
MFIC icon
3916
PUT
MidCap Financial Investment
MFIC
$811M
$519K ﹤0.01%
40,000
SU icon
3917
PUT
Suncor Energy
SU
$75.4B
$518K ﹤0.01%
+25,000
New +$500K
SOFIW
3918
DELISTED
SoFi Technologies, Inc. Warrants
SOFIW
$518K ﹤0.01%
82,627
-41,094
-33% -$249K
SLQT icon
3919
PUT
SelectQuote
SLQT
$132M
$517K ﹤0.01%
+40,000
New +$602K
YSG
3920
Yatsen Holding
YSG
$322M
$517K ﹤0.01%
+27,113
New +$828K
ABCL icon
3921
AbCellera Biologics
ABCL
$1.62B
$515K ﹤0.01%
+25,693
New +$454K
KE
3922
Kimball Electronics
KE
$593M
$514K ﹤0.01%
19,959
-3,600
-15% -$82.3K
SO icon
3923
CALL
Southern Company
SO
$109B
$514K ﹤0.01%
+8,300
New +$534K
GBT
3924
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
$510K ﹤0.01%
+20,000
New +$588K
KAI icon
3925
Kadant
KAI
$3.72B
$508K ﹤0.01%
2,487
+103
+4% +$20.3K

Similar funds

D.E. Shaw & Co's Q3 2021 Portfolio in Review

As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.

  • D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.